1Seifer DB,Scott RT Jr,Bergh PA,et al.Women with declining ovarian reserve may demonstrate a decrease in day 3 serum inhibin B before a rise in day 3 follicle-stimulating hormone.Fertil Steril,1999,72:63-65.
2Eldar GT,Margalioth E J,Ben CA,et al.Serum inhibin B levels measured early during FSH administration for IVF may be of value in predicting the number of oocytes to be retrieved in normal and low responders.Hum Reprod,2002,17:2331-2337.
3Fawzy M,Lambert A,Harrison RF,et al.Day 5 inhibin B levels in a treatment cycle are predictive of IVF outcome.Hum Reprod,2002,17:1535-1543.
4Urbancsek J,Hauzman EE,Murber A,et al.Serum CA-125 and inhibin B levels in the prediction of ovarian response to gonadotropin stimulation in in vitro fertilization cycles.Gynecol Endocrinol,2005,21:38-44.
6Delvigne A, Rozenberg S. Review of clinical course and treatment of ovarian hyperstimulation syndrome (OHSS). Hum Reprod Update, 2003, 9(1): 77-96.
7McClure N, Healy DL, Rogers PA, et al. Vascular endothelial growth factor as capillary permeability agent in ovarian hyperstimulation syndrome. Lancet, 1994, 344(8917): 235-136.
8Morris RS, Wong IL, Kirkman E, et al. Inhibition of ovarian- derived prorenin to angiotensin cascade in the treatment of ovarian hyperstimulation syndrome. Hum Reprod, 1995, 10(6): 1355-1358.
9Delbaere A, Bergmann PJ, Gervy-Decoster C, et al. Prorenin and active renin concentrations in plasma and ascites during severe ovarian hyperstimulation syndrome. Hum Reprod, 1997, 12(2): 236- 240.
10Tamarat R, Silvestre IS, Durie M, et al. Angiotensin II angiogenic effect in vivo involves vascular endothelial growth factor-and inflammation related pathways. Lab Invest, 2002, 82(6): 747-756.
